Hereditary angioedema type 1 or 2 - lanadelumab - initial authority application form (PB325)

Use this form to apply for initial PBS-subsidised treatment with lanadelumab for patients aged 12 years or older with hereditary angioedema type 1 or 2.

Page last updated: 1 August 2024.
QC 55886